Peripheral vertigo as onset of an immune-mediated disorder

Kaspranskaya G.R.

Polyclinic No. 1 President`s Affairs Management of the Russian Federation

Chernenkaya V.Yu.

Buyanov Moscow City Clinical Hospital

Fominykh V.V.

Buyanov City Clinical Hospital;
Institute of Higher Nervous Activity and Neurophysiology

Brylev L.V.

Buyanov City Clinical Hospital;
Institute of Higher Nervous Activity and Neurophysiology;
Solovyov Scientific and Practical Psychoneurological Center

SPIN RSCI: 9749-8920
Scopus AuthorID: 23110301900
ORCID: 0000-0003-2314-6523

Peripheral vertigo as onset of an immune-mediated disorder

Authors:

Kaspranskaya G.R., Chernenkaya V.Yu., Fominykh V.V., Brylev L.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(2): 97‑100

DOI: 10.17116/jnevro202212202197

Downloaded: 40

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kaspranskaya GR, Chernenkaya VYu, Fominykh VV, Brylev LV. Peripheral vertigo as onset of an immune-mediated disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(2):97‑100. (In Russ.)
https://doi.org/10.17116/jnevro202212202197

Close metadata

In this article we present a clinical case of a female patient, 45 years old, with autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD) beginning clinically with vertigo. According to high frequency of vestibular symptoms at the beginning and high frequency of admission to otoneurologist GAD-associated pathology should be included in differential diagnosis in complicated clinical cases with vertigo. These patients should be sent to neurologist.

Keywords:

vertigo

glutamate decarboxylase

GAD

encephalitis

Authors:

Kaspranskaya G.R.

Polyclinic No. 1 President`s Affairs Management of the Russian Federation

Chernenkaya V.Yu.

Buyanov Moscow City Clinical Hospital

Fominykh V.V.

Buyanov City Clinical Hospital;
Institute of Higher Nervous Activity and Neurophysiology

Brylev L.V.

Buyanov City Clinical Hospital;
Institute of Higher Nervous Activity and Neurophysiology;
Solovyov Scientific and Practical Psychoneurological Center

SPIN RSCI: 9749-8920
Scopus AuthorID: 23110301900
ORCID: 0000-0003-2314-6523

Received:

15.09.2021

Accepted:

20.09.2021

List of references:

Strupp M, Dieterich M, Brandt T. The Treatment and Natural Course of Peripheral and Central Vertigo. Deutsches Aerzteblatt Online. 2013. https://doi.org/10.3238/arztebl.2013.0505
Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017;156(3 suppl):1-47. https://doi.org/10.1177/0194599816689667
Graus F, Saiz A, Dalmau J. GAD antibodies in neurological disorders — insights and challenges. Nat Rev Neurol. 2020;16(7):353-365. https://doi.org/10.1038/s41582-020-0359-x
Seliverstov Y, Melnik E, Fominykh V, et al. Stiff-Person Spectrum Disorders Can Be Highly Underdiagnosed in Russia: a Retrospective Analysis (2376). Neurology. 2020;94(15 suppl):2376. Accessed August 8, 2021. https://n.neurology.org/content/94/15_Supplement/2376.abstract
Nene Y, Mehta T, Pawar S, Patil G, Ichaporia NR. A Case of Anti-glutamic Acid Decarboxylase-65 Antibody Positive Stiff Person Syndrome Presenting Initially as Acute Peripheral Vestibulopathy, Leading to Delayed Diagnosis After Multiple Hospitalizations. Cureus. 2019. https://doi.org/10.7759/cureus.6083
Feldman D, Otero-Millan J, Shaikh AG. Gravity-Independent Upbeat Nystagmus in Syndrome of Anti-GAD Antibodies. Cerebellum. 2019;18(2):287-290. https://doi.org/10.1007/s12311-018-0972-z
Martins AI, Carvalho JN, Amorim AM, et al. Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies. Journal of Neuro-Ophthalmology. 2018;38(1):32-35. https://doi.org/10.1097/WNO.0000000000000547
Chen Y, Morgan ML, Espino Barros Palau A, et al. Downbeat down south. Survey of Ophthalmology. 2015;60(2):177-181. https://doi.org/10.1016/j.survophthal.2014.06.004
Muñiz-Castrillo S, Vogrig A, Joubert B, et al. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies. Cerebellum. 2020;19(5):715-721. https://doi.org/10.1007/s12311-020-01159-x
Wang Y, Tourkevich R, Bosley J, et al. Ocular Motor and Vestibular Characteristics of Antiglutamic Acid Decarboxylase — Associated Neurologic Disorders. Journal of Neuro-Ophthalmology. 2020. https://doi.org/10.1097/WNO.0000000000001084

Close metadata